The present study evaluates the metabolic profile of blood plasma for distinguishing prostate cancer (PCa) patients with metastases (n=30) and without metastases (n=35) using 1H-NMR spectroscopy. Our data showed significant lower concentration of leucine, valine, isoleucine, glycerophosphocholine, glutamine and acetoacetate in PCa patents with metastases as compared to patients without metastases. Results provided an insight into the alterations in the metabolic pathways in PCa and indicated that NMR spectroscopy may help in determining potential biomarker/s for the diagnosis of PCa patients with metastases.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords